- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
A biosimilar drug, or biosimilar, is is a medicine that is very close in structure and function to the original biologic drug. Biosimilars can be manufactured when the patent of the original product expires. Biosimilars are an equal substitute for its brand name drug and can be used to treat the same disease.
Showing 1–12 of 28 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
TNF alpha |
Biosimilar , Monoclonal Antibody |
Amgevita® |
50 mg/mL |
– |
2 mg |
-80°C |
2021.12 |
265,50 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hulio® |
50 mg/mL |
– |
2 mg |
-80°C |
2023.02 |
265,50 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hukyndra® |
100 mg/mL |
– |
2 mg |
-80°C |
2023.10 |
309,60 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Yuflyma® |
100 mg/mL |
– |
4 mg |
-80°C |
2024.02 |
309,60 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Idacio® |
50 mg/mL |
– |
2 mg |
-80°C |
2023.10 |
310,50 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Imraldi® |
50 mg/mL |
– |
2 mg |
-80 °C |
2023.10 |
265,50 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hyrimoz® |
50 mg/mL |
– |
2 mg |
-80°C |
2024.06 |
265,50 € |
||
C5 complement protein |
Biosimilar , Monoclonal Antibody |
Bekemv® |
10 mg/mL |
– |
3 mg |
tba |
tba |
391,00 € |
||
C5 complement protein |
Biosimilar , Monoclonal Antibody |
Epysqli® |
10 mg/mL |
– |
3 mg |
tba |
tba |
391,00 € |
||
EPO receptor |
Biosimilar , Glycoprotein hormone |
Silapo® |
40000 IU/mL |
– |
5000 IU |
-80°C |
2022.08 |
336,60 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Erelzi® |
50 mg/mL |
– |
4 mg |
-80°C |
2023.04 |
237,60 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Benepali® |
50 mg/mL |
– |
4 mg |
-80°C |
2023.11 |
237,60 € |
||
TNF alpha |
Biosimilar , Fusion protein |
Nepexto® |
50 mg/mL |
– |
4 mg |
-80 °C |
2023.08 |
|||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Remsima® |
10 mg/mL |
– |
3 mg |
tba |
tba |
233,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Flixabi® |
10 mg/mL |
– |
2 mg |
-80°C |
2025.01 |
232,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Inflectra® |
10 mg/mL |
– |
2 mg |
- 80°C |
2027.03 |
233,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Zessly® |
10 mg/mL |
– |
2 mg |
-80°C |
2022.10 |
210,60 € |
||
VEGF-A |
Biosimilar , Monoclonal Antibody |
Ranivisio® |
10 mg/mL |
– |
0.2 mg |
tba |
tba |
680,00 € |
||
VEGF |
Biosimilar , Monoclonal Antibody |
Ximluci® |
10 mg/mL |
– |
0,21 mg |
tba |
tba |
680,00 € |
||
CD20 |
Biosimilar , Monoclonal Antibody |
Ruxience® |
10 mg/mL |
– |
2 mg |
tba |
tba |
196,00 € |
||
CD20 |
Biosimilar , Monoclonal Antibody |
Truxima® |
10 mg/mL |
– |
2 mg |
tba |
tba |
234,00 € |
||
CD20 |
Biosimilar , Monoclonal Antibody |
Rixathon® |
10 mg/mL |
– |
2 mg |
-80 °C |
2026.03 |
311,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Herzuma® |
21 mg/mL |
– |
6 mg |
tba |
tba |
356,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Ontruzant® |
21 mg/mL |
– |
2 mg |
tba |
tba |
159,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Kanjinti® |
21 mg/mL |
– |
6 mg |
-80°C |
2025.01 |
356,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Zercepac® |
21 mg/mL |
– |
6 mg |
-80°C |
2026.08 |
356,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Ogivri® |
21 mg/mL |
– |
6 mg |
-80°C |
2025.10 |
438,00 € |
||
HER2 |
Biosimilar , Monoclonal Antibody |
Trazimera® |
21 mg/mL |
– |
2 mg |
-80 °C |
2026.09 |
159,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany